F. Cardenal
Institut Català d'Oncologia · 37 works · 942 citations · h-index 14
Top works
- Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
- A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
- Typhlitis Associated With Docetaxel Treatment
- Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer
- A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin–docetaxel, plus radical concurrent chemoradiotherapy with cisplatin–docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer
- C3-02: Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Mature results of the SLCG 0008 study
- Extrapyramidal reaction associated with ondansetron
- Etoposide-related acral erythema
- Lenograstim as Support for ACE Chemotherapy of Small-Cell Lung Cancer
- Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine
- Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer
- Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study
- Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer
- Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature
- Brain functional connectivity in lung cancer population: an exploratory study
- Continued high activity of figitumumab (CP-751,871) combination therapy in squamous lung cancer
- Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy
- Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial
- [Superior vena cava syndrome due to tuberculous mediastinal fibrosis. Report of two cases (author's transl)].
- Phase I trial of vorinostat in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations after erlotinib progression